These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31982581)

  • 1. Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder.
    Malow BA; Findling RL; Schroder CM; Maras A; Breddy J; Nir T; Zisapel N; Gringras P
    J Am Acad Child Adolesc Psychiatry; 2021 Feb; 60(2):252-261.e3. PubMed ID: 31982581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P; Nir T; Breddy J; Frydman-Marom A; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders.
    Schroder CM; Banaschewski T; Fuentes J; Hill CM; Hvolby A; Posserud MB; Bruni O
    Expert Opin Pharmacother; 2021 Dec; 22(18):2445-2454. PubMed ID: 34314281
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
    Schroder CM; Malow BA; Maras A; Melmed RD; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
    J Autism Dev Disord; 2019 Aug; 49(8):3218-3230. PubMed ID: 31079275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder.
    Zisapel N
    Expert Rev Clin Pharmacol; 2022 Feb; 15(2):175-185. PubMed ID: 35285365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
    Schröder CM; Broquère MA; Claustrat B; Delorme R; Franco P; Lecendreux M; Tordjman S
    Encephale; 2022 Jun; 48(3):294-303. PubMed ID: 35120753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insomnia in children affected by autism spectrum disorder: The role of melatonin in treatment.
    Bruni O; Biggio G; Malorgio E; Nobili L
    Sleep Med; 2024 Jul; 119():511-517. PubMed ID: 38805858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial.
    Roth T; Nir T; Zisapel N
    Nat Sci Sleep; 2015; 7():13-23. PubMed ID: 25678831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
    Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.
    Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J
    JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
    Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
    JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Banaschewski T; Johnson M; Nagy P; Otero IH; Soutullo CA; Yan B; Zuddas A; Coghill DR
    CNS Drugs; 2018 May; 32(5):455-467. PubMed ID: 29790103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
    Lemoine P; Garfinkel D; Laudon M; Nir T; Zisapel N
    Ther Clin Risk Manag; 2011; 7():301-11. PubMed ID: 21845053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders.
    Yuge K; Nagamitsu S; Ishikawa Y; Hamada I; Takahashi H; Sugioka H; Yotsuya O; Mishima K; Hayashi M; Yamashita Y
    BMC Psychiatry; 2020 Sep; 20(1):445. PubMed ID: 32912180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.